Literature DB >> 15057984

Hypercalciuria and kidney calcifications in terminal 4q deletion syndrome: further evidence for a putative gene on 4q.

Mario Giuffrè1, Simona La Placa, Maurizio Carta, Antonella Cataliotti, Maria Marino, Maria Piccione, Francesco Pusateri, Ferdinando Meli, Giovanni Corsello.   

Abstract

We report a newborn girl with a de novo terminal 4q deletion (q31.3 --> qter) and a characteristic phenotype of minor facial anomalies, cleft palate, congenital heart defect, abnormalities of hands and feet, and postnatal onset of growth deficiency. Laboratory studies showed excessive urinary calcium excretion on standard milk formula and on oral calcium load. Blood measurements of parathyroid hormone, calcitonin, bicarbonate, calcium, phosphorus, magnesium, sodium, chlorine, potassium, and urinary measurements of phosphorus, magnesium, sodium, chlorine, potassium were normal for age. At 2 months of life, ultrasonography showed kidney calcifications. Clinical and laboratory data support the diagnosis of absorptive hypercalciuria or abnormal regulation of calcium-sensing receptors in the renal tubules. The evidence of hypercalciuria and kidney calcifications associated with 4q terminal deletion strengthens the hypothesis that a putative gene for hypercalciuria is located on the terminal segment of chromosome 4q. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15057984     DOI: 10.1002/ajmg.a.20561

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  Association of vitamin-D and calcitonin receptor gene polymorphism in paediatric nephrolithiasis.

Authors:  Hemant Kumar Bid; Himanshu Chaudhary; Rama Devi Mittal
Journal:  Pediatr Nephrol       Date:  2005-04-26       Impact factor: 3.714

Review 2.  Pathophysiology of hypercalciuria in children.

Authors:  Tarak Srivastava; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2007-04-27       Impact factor: 3.714

3.  Renal failure associated with APECED and terminal 4q deletion: evidence of autoimmune nephropathy.

Authors:  Mohammed Al-Owain; Namik Kaya; Hamad Al-Zaidan; Ibrahim Bin Hussain; Hadeel Al-Manea; Hindi Al-Hindi; Shelley Kennedy; M Anwar Iqbal; Hamad Al-Mojalli; Albandary Al-Bakheet; Anne Puel; Jean-Laurent Casanova; Saleh Al-Muhsen
Journal:  Clin Dev Immunol       Date:  2010-12-14

Review 4.  Terminal chromosome 4q deletion syndrome in an infant with hearing impairment and moderate syndromic features: review of literature.

Authors:  Barbara Vona; Indrajit Nanda; Cordula Neuner; Jörg Schröder; Vera M Kalscheuer; Wafaa Shehata-Dieler; Thomas Haaf
Journal:  BMC Med Genet       Date:  2014-06-25       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.